Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Study issues warning: Opioid inhibitor naltrexone (often used to treat addictions) can reduce feelings of social connection

_________

Sci­ence has long known that hav­ing pos­i­tive social con­nec­tion is impor­tant to a hap­py and healthy life. But less is under­stood about how our brains sup­port and encour­age con­nect­ing with oth­ers.

While pri­or research has sug­gest­ed oxy­tocin plays a role in nur­tur­ing and trust­ing oth­ers, there­by strength­en­ing social bonds, many researchers also sus­pect that brain opi­oids are impor­tant to social con­nec­tion. Read the rest of this entry »

E-Newsletter: Neuroimaging + machine learning can predict, with 96% accuracy, whether high-risk 6-month-old babies will develop autism spectrum disorder (ASD) by age 2

Researchers use brain imag­ing and machine learn­ing to pre­dict which high-risk infants will devel­op autism. Cred­it: Car­oli­na Insti­tute for Devel­op­men­tal Dis­abil­i­ties.

_____

Time for Sharp­Brains’ June e-newslet­ter, fea­tur­ing fas­ci­nat­ing sci­en­tif­ic find­ings, promis­ing assess­ments, ther­a­pies and brain health mon­i­tor­ing tools…and some fun opti­cal illu­sions 🙂

New research

New tools

New thinking

Upcoming Events

__________

Final­ly, you may want to Test your Brain and Mind with these 9 Clas­sic Opti­cal Illu­sions 🙂

 

Have a great sum­mer!

The Sharp­Brains Team

Study combines neuroimaging with machine learning to predict, with 96% accuracy, whether high-risk 6-month-old babies will develop autism spectrum disorder (ASD) by age 2

Researchers use brain imag­ing and machine learn­ing to pre­dict which high-risk infants will devel­op autism. Cred­it: Car­oli­na Insti­tute for Devel­op­men­tal Dis­abil­i­ties.

A Sin­gle Brain Scan Has Been Used to Accu­rate­ly Pre­dict Autism at Just 6 Months Old (Sci­ence alert)

Researchers have used brain scans and arti­fi­cial intel­li­gence to spot dif­fer­ences in how key areas of infant brains syn­chro­nise, allow­ing them to accu­rate­ly pre­dict which babies would devel­op autism spec­trum dis­or­der (ASD) as a toddler…The research, led by sci­en­tists from the Uni­ver­si­ty of North Car­oli­na at  Chapel Hill and Wash­ing­ton Uni­ver­si­ty, comes hot on the heels of an ear­li­er study that used two scans tak­en at 6 and 12 months to make a sim­i­lar pre­dic­tion.

Not only has this new method reduced the num­ber of scans required to make the Read the rest of this entry »

Next: Increasing neuroplasticity via neuroimaging-enhanced brain stimulation

apparatus

– Illus­tra­tive image from U.S. Patent No. 7,756,584

Today we high­light a very thought-pro­vok­ing (pun intend­ed) patent by Advanced Neu­ro­mod­u­la­tion Sys­tems. (As men­tioned, we are fea­tur­ing a foun­da­tion­al Per­va­sive Neu­rotech patent a day, from old­er to new­er by issue date)

U.S. Patent No. 7,756,584: Meth­ods and appa­ra­tus for effec­tu­at­ing a last­ing change in a neur­al-func­tion of a patient

  • Assignee(s): Advanced Neu­ro­mod­u­la­tion Sys­tems, Inc.
  • Inventor(s): W. Dou­glas Sheffield, Andrew D. Fir­lik, Kat­ri­na S. Fir­lik
  • Tech­nol­o­gy Cat­e­go­ry: Tran­scra­nial Stim­u­la­tion
  • Issue Date: July 13, 2010

SharpBrains’ Take:

The ‘584 patent dis­clos­es tech­niques for iden­ti­fy­ing stim­u­la­tion sites of the brain to facil­i­tate plas­tic­i­ty that can aid in reha­bil­i­ta­tion of dys­func­tion result­ing from a stroke, trau­mat­ic injury, etc. Read the rest of this entry »

Neuroimaging as a marketing tool: Key Neurotech Patent #2

– Illus­tra­tive image from U.S. Patent No. 6,099,319

As men­tioned, we are fea­tur­ing a foun­da­tion­al Per­va­sive Neu­rotech patent a day, from old­er to new­er by issue date. Today we are shar­ing a 2000 patent assigned to The Nielsen Com­pa­ny.

U.S. Patent No. 6,099,319: Neu­roimag­ing as a mar­ket­ing tool

  • Assignee(s): The Nielsen Com­pa­ny
  • Inventor(s): Ger­ald Zalt­man, Stephen M. Koss­lyn
  • Tech­nol­o­gy Cat­e­go­ry: Hybrid
  • Issue Date: August 8, 2000

SharpBrains’ Take:

The ‘319 patent is one of Nielsen’s sev­er­al patents that relate to ana­lyz­ing brain data in response to a wide vari­ety of stim­uli for pur­pos­es of eval­u­at­ing the stim­uli, such as dis­cern­ing emo­tion­al respons­es to sen­so­ry inputs. Read the rest of this entry »

Watch All Recordings Now (40+ Speakers, 12+ Hours)

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters and more, SharpBrains is an independent market research firm tracking health and performance applications of brain science.

Follow us and Engage via…

twitter_logo_header
RSS Feed

Search for anything brain-related in our article archives

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.